Therapeutics

Validated molecular targets

ACCANIS´ therapeutic program builds upon validated molecular targets that are tested in order to best represent the human disease.

Read more ...

Technology

Messenger RNA

ACCANIS is developing optimized, proprietary in vitro transcribed (IVT) mRNA with broad and long-acting therapeutic potential surpassing protein-based therapeutics.

Read more ...